Esophageal Squamous Cell Carcinoma — Trials

Esophageal Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

555 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 212
Recruiting: 119
Ph III recruiting: 20
Growth YoY: +61.4%
Industry share: 23%
Top sponsor: Fudan University
Termination share: 25%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (35)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07016737	Immunochemotherapy ± Salvage Chemoradiation for Local Recurrence of Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy(ESO-Nanjing12)	enrolling by invitation	Phase 3	79	Ye jinjunOTHER	1	Jun 12, 2025	clinicaltrials

Data updated 22 days agoSource updated Jun 12, 2025source: clinicaltrials